BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29181680)

  • 21. Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database.
    Hallet J; Cunha AS; Adam R; Goéré D; Azoulay D; Mabrut JY; Muscari F; Laurent C; Navarro F; Pessaux P;
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):894-903. PubMed ID: 27573524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.
    Liu W; Wang HW; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Aug; 45(8):1349-1356. PubMed ID: 31054852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in Metastasis Site by Primary Location in Colon Cancer.
    Amri R; Bordeianou LG; Sylla P; Berger DL
    J Gastrointest Surg; 2015 Aug; 19(8):1522-7. PubMed ID: 25933582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of metastatic patterns after curative colorectal cancer surgery based on primary tumor location].
    Zhang J; Han G; Jiang Z; Wang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):780-4. PubMed ID: 27452756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a difference in survival between right- versus left-sided colon cancers?
    Meguid RA; Slidell MB; Wolfgang CL; Chang DC; Ahuja N
    Ann Surg Oncol; 2008 Sep; 15(9):2388-94. PubMed ID: 18622647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-anatomical colonic resections: splenic flexure and transverse colectomy. Central vascular ligation is crucial for survival.
    Reddavid R; Esposito L; Evangelista A; Sofia S; Degiuli M
    Minerva Chir; 2019 Apr; 74(2):176-186. PubMed ID: 30037179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].
    Gao X; Yu G; Liu P; Hao L; Liu L; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):647-653. PubMed ID: 28643309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study.
    Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J
    Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.
    Karim S; Brennan K; Nanji S; Berry SR; Booth CM
    JAMA Oncol; 2017 Oct; 3(10):1386-1392. PubMed ID: 28594974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection.
    Garajova I; Balsano R; Tommasi C; Dalla Valle R; Pedrazzi G; Ravaioli M; Spallanzani A; Leonardi F; Santini C; Caputo F; Riefolo M; Giuffrida M; Gelsomino F
    Acta Biomed; 2020 Dec; 92(1):e2021061. PubMed ID: 33682832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis.
    Chen TH; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Huang SC; Cheng HH; Chau GY; Hsia CY; Lei HJ; Chou SC; Chao Y; Teng HW
    J Gastrointest Surg; 2021 Mar; 25(3):650-661. PubMed ID: 33201458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the Impact of Primary Tumour Location on Survival After Resection of Colorectal Liver Metastases: A Propensity Weighted Retrospective Cohort Study.
    Borakati A; Froghi F; Shetye A; Fusai GK; Davidson BR; Mirnezami R
    World J Surg; 2022 Jul; 46(7):1734-1755. PubMed ID: 35325347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    Yan XL; Wang K; Bao Q; Wang HW; Jin KM; Su YM; Xing BC
    J Surg Oncol; 2022 May; 125(6):1002-1012. PubMed ID: 35171534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oncologic safety of left colectomy with modified complete mesocolic excision for distal transverse colon cancer: Comparison with descending colon cancer.
    Song I; Park JW; Lim HK; Kim MJ; Kim MJ; Park SC; Oh JH; Oh HK; Kim DW; Kang SB; Ryoo SB; Jeong SY; Park KJ;
    Eur J Surg Oncol; 2021 Nov; 47(11):2857-2864. PubMed ID: 34119379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
    Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
    Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.